Manager -Biospecimen at Bristol-Myers Squibb

Hyderabad, Telangana, India

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, Clinical ResearchIndustries

Requirements

  • Minimum of 3-4 years academic, biotech, healthcare or pharmaceutical industry experience or equivalent
  • Basic understanding of clinical and biomedical research, GCP, GLP, CLIA, data management, risk management and regulatory issues
  • Demonstrated clinical trial experience, healthcare/medical/laboratory or equivalent
  • Vendor experience preferred (e.g., Central Labs, Bioanalytical, Biomarker, CROs, Biospecimen Storage Vendors, etc.)
  • Biospecimen management experience preferred but not mandatory
  • Ability to effectively communicate, create and deliver presentation/information/data to knowledgeable audiences, with limited supervision
  • Ability to adopt a biopharma enterprise-wide and entrepreneurial mindset, to act with a sense of urgency, accountability and integrity
  • Knowledge of clinical trials and the end-to-end management of biospecimens
  • Travel requirement is minimal, 0%-5% of time, when organization requests

Responsibilities

  • Oversee and manage the complete lifecycle of biospecimens collected for clinical studies with minimal supervision
  • Provide shipping/sample movement and management including requests, query and inventory reports, follow up active issues with vendors, prepare sample management related reports, review/prepare tracking activities (such as vendor manifests/inventories, tissue/blood match pairing, depleted/non-viable samples, loading documents to Shared Drive folders, etc.)
  • Independently review clinical study protocol providing comparison of vendor statement of work and biospecimen relevant sections and feedback with support as needed
  • Perform routine vendor management responsibilities, including requesting and/or accessing necessary vendor/system inventory files to perform specimen tracking
  • Under direction, create biospecimen tracker using various tracking tools (MS Excel, Spotfire, Tableau or internal systems (if applicable))
  • Exercise judgment within policy and procedure boundaries, troubleshoot routine problems and understand when appropriate to ask for guidance
  • Work closely with Clinical Teams to develop and implement biospecimen management plan for BMS-sponsored Phase 1-4 clinical trials
  • Oversee timelines for specimen data delivery to enable quick decision-making and ensure BMS’s continuous competitive advantage

Skills

biospecimen management
clinical trials
sample management
vendor management
inventory reports
shipping coordination
query resolution
tracking activities
Phase 1-4 studies

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI